awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35132410-2082BB6F-C680-40F5-964B-690C4FCF0B69
Q35132410-2082BB6F-C680-40F5-964B-690C4FCF0B69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35132410-2082BB6F-C680-40F5-964B-690C4FCF0B69
Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?
P2860
Q35132410-2082BB6F-C680-40F5-964B-690C4FCF0B69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35132410-2082BB6F-C680-40F5-964B-690C4FCF0B69
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6571a48632b2fe0531d49b4d6b1ac5d207b6dd0a
P2860
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.